|
| DOE-STD-1121-98
health physicist as an interface to medical treatment. The impact of therapeutic measures on the outcome
of dosimetric evaluations is also discussed.
Quality assurance issues associated with bioassay measurements, evaluations of intake, and
internal dose are presented in Section 11.
1.5 USE OF NON-GOVERNMENTAL STANDARDS
To the extent possible, this guidance document is written to be consistent with existing non-
governmental standards for internal dosimetry, including:
C
ANSI N42.22-1999, American National StandardTraceability of Radioactive Sources to the
National Institute of Standards and Technology (NIST) and Associated Instrument Quality Control
C
ANSI N42.23-1996, Measurement and Associated Instrumentation Quality Assurance for
Radioassay Laboratories
C
ANSI N323a-1997, American National Standard for Radiation Protection Instrumentation Test
and Calibration
C
ANSI Z88.2-1992, American National Standard for Respiratory Protection.
C
HPS N13.1-1999, Guide to Sampling and Monitoring Releases of Airborne Radioactive
Substances from the Stacks and Ducts of Nuclear Facilities
C
HPS N13.6-1999, Practice for Occupational Radiation Exposure Records Systems
C
HPS N13.12-1999, Surface and Volume Radioactivity Standards for Clearance
C
HPS N13.14-1994, Internal Dosimetry Programs for Tritium Exposure, Minimum Requirements
C
HPS N13.22-1995, Bioassay Programs for Uranium
C
HPS N13.30-1996, Performance Criteria for Radiobioassay
C
HPS N13.39-2000, Design of Internal Dosimetry Programs
C
HPS N13.42-1997, Internal Dosimetry for Mixed Fission and Activation Products
4
|
Privacy Statement - Press Release - Copyright Information. - Contact Us |